A non-randomized, open-label, single arm study to evaluate the effect of Yokukansan on the dispositions of donepezil hydrochloride and risperidone (clinical pharmacokinetic analysis)
Not Applicable
Recruiting
- Conditions
- Dementia or Schizophrenia
- Registration Number
- JPRN-UMIN000026273
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not available
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Variabilities in blood concentrations of donepezil hydrochloride, risperidone and their metabolites before and after co-treatment of Yokukansan
- Secondary Outcome Measures
Name Time Method Variabilities in blood concentrations of donepezil hydrochloride, risperidone and their metabolites before and after co-treatment of Yokukansan according to the genotypes of pharmacokinetic related genes